OrthoCyte is spun out to develop novel stem cell technology for musculoskeletal disorders

Arnold Caplan, PhD from Case Western will serve as CSO.  He was the founder of Osiris Therapeutics.

BioTime Forms New Subsidiary, OrthoCyte Corporation, to Develop Treatments for Orthopedic Conditions Using Stem Cell Technology  (BusinessWire)